Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case–control analysis

Abstract

Metformin, sulfonylurea, and TZD treated patients were associated with lower risks of AA development, but not DPP-4 inhibitors or alpha-glucosidase inhibitor. The protective effects of hypoglycemic agents are further confirmed by the dose responsive relations in metformin and sulfonylurea groups.